Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$705.89 - $766.39 $5.64 Million - $6.12 Million
-7,984 Reduced 94.14%
497 $359 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $609,216 - $820,851
-1,111 Reduced 11.58%
8,481 $5.01 Million
Q1 2022

May 17, 2022

SELL
$595.12 - $698.43 $597,500 - $701,223
-1,004 Reduced 9.48%
9,592 $6.7 Million
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $23,913 - $29,522
-44 Reduced 0.41%
10,596 $6.69 Million
Q3 2021

Nov 16, 2021

SELL
$574.03 - $680.96 $1.01 Million - $1.19 Million
-1,751 Reduced 14.13%
10,640 $6.44 Million
Q2 2021

Aug 17, 2021

BUY
$472.8 - $558.54 $5.86 Million - $6.92 Million
12,391 New
12,391 $6.92 Million
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $695,072 - $962,382
-2,320 Closed
0 $0
Q1 2019

May 16, 2019

SELL
$372.08 - $439.57 $12,650 - $14,945
-34 Reduced 1.44%
2,320 $953,000
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $790,520 - $948,756
2,354 New
2,354 $879,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.